Antihypertensive drug treatment and the risk for intra-hemodialysis hypotension.
Carmine ZoccaliGiovanni TripepiPaola CarioniEdouard L FuFriedo W DekkerVianda S StelKitty J JagerFrancesca MallamaciJeffrey L HymesFranklin W MadduxStefano StuardPublished in: Clinical journal of the American Society of Nephrology : CJASN (2024)
The study suggests that using beta and alpha-beta blockers, ACE inhibitors or angiotensin II receptor blockers, and diuretics may increase the risk of IDH in HD patients compared to CCB use.